A Conversation with EPO and USPTO Concerning the Patentability of Life Sciences Inventions
Thursday, September 28, 2017
D’Agostino, Lipton Hall, 108 West 3rd Street

The SCOTUS decisions in Mayo and Alice have spurred uncertainty concerning the patentability of life sciences inventions in the U.S.  A growing perception is that the European Patent Office (EPO) is treating more favorably European equivalents of life sciences inventions which are unable to secure patent protection in the U.S.  Such an outcome would undermine the global integration of patent standards and would increase the cost and complexity of obtaining global patent family protection in the life sciences.

This state of affairs calls for discussing patentability requirements at an international level.  Our panel will do so by comparing and contrasting the standards applied to life sciences invention at the EPO and the United States Patent and Trademark Office (USPTO).

The panel will include Klaus-Peter Döpfer (Director, European Patent Office), Oskar Lechner (Director, European Patent Office), Teresa Stanek Rea (partner, Crowell Moring; former Acting Under Secretary of Commerce for Intellectual Property and former Acting Director of the United States Patent and Trademark Office (USPTO), and a current representative of the USPTO.

The panel discussion begins at 6:00 pm and will continue until approximately 7:15 pm, with an opportunity for audience Q&A.  A reception will follow the program.

One credit of New York State CLE is being applied for.